Comparative study of protease hydrolysis reaction demonstrating Normalized Peptide Bond Cleavage Frequency and Protease Substrate Broadness Index.

Two commercial proteases (subtilisin-typed FNA from Bacillus amyloliquefaciens, and chymotrypsin-like NPP from Nocardiopsis prasina), porcine pepsin, porcine pancreatin having protease activity and their combinations were studied in vitro by LC-MS for their ability to digest soy protein isolate (SPI) under conditions close to those found in the stomach (pH 3.7) and small intestine (pH 6.5). The total number of peptides generated, and their size distribution were obtained under each set of the digestion conditions. These peptides were grouped according to their C-terminal amino acid (AA) residue (P1) and mass, based on which two concepts were proposed, i.e., Normalized Peptide Bond Cleavage Frequency (NPBCF) and Protease Substrate Broadness Index (PSBI). At pH 3.7, FNA+pepsin increased PSBI vs. pepsin alone by 2.7 and 4.9 percentage points (p.p.) at a SPI:protease ratio of 20:1 and 100:1, respectively. At pH 6.5, FNA+pancreatin improved PSBI by 9.1 and 10.2 p.p. at SPI:protease 20:1 and 100:1, respectively, vs. pancreatin alone. NPP generated 38% more peptides than FNA when administered with pancreatin at SPI:protease 200:1:1 and pH 6.5, but FNA alone (28.9) or FNA+pancreatin (29.1) gave a higher PSBI than pancreatin (22.2), NPP (20.3) and NPP+pancreatin (22.0). At pH 3.7 FNA generated 59% and 39% of peptides of pepsin at SPI:protease of 20:1 and 100:1, respectively, and both groups of peptides had similar size distribution. At pH 6.5 more small sized peptides were generated by FNA or FNA+pancreatin than pancreatin and NPP alone or pancreatin+NPP. In conclusion, FNA showed complementary effects with pepsin and pancreatin in terms of PSBI and generated more small sized peptides compared to NPP.
Competing Interests: E. I. du Pont de Nemours and Company provided support in the form of R&D budget for all authors. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The protease FNA and soy protein isolate Supro 760 described in the “M&M” section are commercial products provided by DuPont for this research. There are no patents, products in development or other marketed products associated with this research to be declared.